Have a personal or library account? Click to login
Transdermal delivery of tolterodine tartrate for overactive bladder treatment: In vitro and in vivo evaluation Cover

Transdermal delivery of tolterodine tartrate for overactive bladder treatment: In vitro and in vivo evaluation

Acta Pharmaceutica
Volume 67 (2017): Issue 3 (September 2017)
By: Rajan Rajabalaya,  Chung Yee Mun,  Jestin Chellian,  Srikumar Chakravarthi and  Sheba R. David  
Open Access
|Aug 2017

Authors

Rajan Rajabalaya

PAPRSB Institute of Health Sciences, Universit Brunei Darussalam, Brunei Darussalam
School of Pharmacy, International Medical University, Kuala Lumpur, Malaysia

Chung Yee Mun

School of Pharmacy, International Medical University, Kuala Lumpur, Malaysia

Jestin Chellian

School of Pharmacy, International Medical University, Kuala Lumpur, Malaysia

Srikumar Chakravarthi

School of Pharmacy, International Medical University, Kuala Lumpur, Malaysia
School of Medicine, Perdana University, Jalan MAEPS Perdana, Malaysia

Sheba R. David

sdsheba@gmail.com

PAPRSB Institute of Health Sciences, Universit Brunei Darussalam, Brunei Darussalam
School of Pharmacy, International Medical University, Kuala Lumpur, Malaysia
DOI: https://doi.org/10.1515/acph-2017-0027 | Journal eISSN: 1846-9558 | Journal ISSN: 1330-0075
Journal RSS Feed
Language: English
Page range: 325 - 339
Accepted on: May 11, 2017
Published on: Aug 30, 2017
Published by: Croatian Pharmaceutical Society
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year
Keywords:
tolterodine tartrate,
transdermal,
overactive bladder,
matrix patches,
permeation
Related subjects:
Pharmacy,
Pharmacy, other

© 2017 Rajan Rajabalaya, Chung Yee Mun, Jestin Chellian, Srikumar Chakravarthi, Sheba R. David, published by Croatian Pharmaceutical Society
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.

Previous articleVolume 67 (2017): Issue 3 (September 2017)Next article